Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Frontiers in Physiology
|
February 23, 2018
TNF-α Increases Production of Reactive Oxygen Species through Cdk5 Activation in Nociceptive Neurons
Rodrigo Sandoval, Pablo Lazcano, Franco Ferrari, et al.
Revista Medica De Chile
|
December 1, 2017
[The impact of the orthopedic surgeons' attire on patient preferences]
Stefan Lozic, Pedro Christian Aravena, Nicolás Martínez, et al.
Frontiers in Pharmacology
|
May 20, 2026
Cdk5 modulates orofacial pain through P2X2/3 purinergic receptor-mediated signaling in trigeminal neurons
Rodrigo Sandoval, Nicolás Pinto-Pardo, Camila Duran, et al.
Pediatric Blood & Cancer
|
April 5, 2026
Challenges in Launching a Precision Pediatric Oncology Program in Argentina
María Mercedes Paladino, Nicolás Pinto, David Verón, et al.
Pediatric Blood & Cancer
|
May 15, 2026
Immune Response and Safety of Anti-NeuGcGM3 Anti-Idiotype Vaccine Racotumomab in Patients With High-Risk Neuroblastoma: An Open-Label, Single-Arm, Multicenter Phase 2 Study in Argentina
Guido Felizzia, Valeria I Segatori, Laura Galluzzo, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Frontiers in Physiology
|
February 23, 2018
TNF-α Increases Production of Reactive Oxygen Species through Cdk5 Activation in Nociceptive Neurons
Rodrigo Sandoval, Pablo Lazcano, Franco Ferrari, et al.
Revista Medica De Chile
|
December 1, 2017
[The impact of the orthopedic surgeons' attire on patient preferences]
Stefan Lozic, Pedro Christian Aravena, Nicolás Martínez, et al.
Frontiers in Pharmacology
|
May 20, 2026
Cdk5 modulates orofacial pain through P2X2/3 purinergic receptor-mediated signaling in trigeminal neurons
Rodrigo Sandoval, Nicolás Pinto-Pardo, Camila Duran, et al.
Pediatric Blood & Cancer
|
April 5, 2026
Challenges in Launching a Precision Pediatric Oncology Program in Argentina
María Mercedes Paladino, Nicolás Pinto, David Verón, et al.
Pediatric Blood & Cancer
|
May 15, 2026
Immune Response and Safety of Anti-NeuGcGM3 Anti-Idiotype Vaccine Racotumomab in Patients With High-Risk Neuroblastoma: An Open-Label, Single-Arm, Multicenter Phase 2 Study in Argentina
Guido Felizzia, Valeria I Segatori, Laura Galluzzo, et al.
Page
of 1